Lyon, France

Henri Combier

This inventor holds 2 USPTO granted patents. Top assignee: Laboratoires Sarget. Active years: 1979-1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henri Combier. Retrieved from https://idiyas.com/inventor/henri-combier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Lyon, FR (1979)
  • Rilleux le Pape, FR (1982)

Company Filing History:


Years Active: 1979-1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Henri Combier in Pharmacological Saponins

Introduction

Henri Combier is an accomplished inventor based in Lyon, France. He has made significant contributions to the field of pharmacology through his innovative work on triterpenic saponins. With a total of 2 patents, his inventions focus on therapeutic applications derived from natural plant extracts.

Latest Patents

One of his latest patents is titled "Triterpenic saponin having pharmacological potency." This invention concerns a new triterpenic saponin derived from caulophyllogenin. The process involves extracting it from varieties of Chrysanthellum and utilizing it for therapeutic purposes. The saponin is characterized as the ester of O-.beta.-D-glucosyl-3.beta.-caulophyllogenin and an oligosaccharide comprising two units of L-rhamnose and two units of D-xylose. It is extracted from vegetable matter and purified using pressurized liquid preparative chromatographic techniques. This saponin is useful in human and veterinary therapeutics in phlebology, rheumatology, and traumatology.

Another significant patent is related to a "Chrysanthellum plant extract." This extract is rich in triterpenic constituents obtained from chrysanthellum and contains as its principal component a triterpenic saponin derivative of echinocystic acid. The glycoside of this saponin contains rhamnose, glucose, and xylose. The extract has been shown to have pharmacological activity, especially analgesic, anti-inflammatory, capillaroprotective, and anti-ulcer activity.

Career Highlights

Henri Combier is associated with Laboratoires Sarget, where he continues to develop innovative solutions in the field of pharmacology. His work has been instrumental in advancing the understanding and application of plant-derived compounds in medical treatments.

Collaborations

He collaborates with notable colleagues such as Gisele Prat and Francois Fauran, contributing to a dynamic research environment focused on pharmacological advancements.

Conclusion

Henri Combier's innovative work in the field of pharmacology, particularly with triterpenic saponins, showcases the potential of natural extracts in therapeutic applications. His contributions continue to influence the development of effective treatments in various medical fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…